We performed multiplex immunohistochemistry (mIHC) to assess the protein expression levels of LAMP2A, CD8, and IFNγ in biopsies from HNSCC who received PD-1 monoclonal antibody treatment. Here, CD8A is linked to head and neck squamous cell carcinoma.